Management of Huntington’s disease: role of tetrabenazine

Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder characterized by progressive involuntary movements, neuropsychiatric disturbances, and cognitive impairment. The use of tetrabenazine (TBZ), a specific inhibitor of vesicular monoamine transporter, is approved for chorea i...

Descripción completa

Detalles Bibliográficos
Autores principales: de Tommaso, Marina, Serpino, Claudia, Sciruicchio, Vittorio
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071349/
https://www.ncbi.nlm.nih.gov/pubmed/21479143
http://dx.doi.org/10.2147/TCRM.S17152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071349/
https://www.ncbi.nlm.nih.gov/pubmed/21479143
http://dx.doi.org/10.2147/TCRM.S17152

Ejemplares similares